The effect of T and B lymphocyte depletion on the protection of mice vaccinated with a Gal E mutant of Salmonella typhimurium.

Immunosuppressive agents were used to determine the relative importance of T and B lymphocytes in conferring protection to mice vaccinated with a live gal E mutant of Salmonella typhimurium, strain G30D. Lymphocyte transformation and serum agglutination tests showed that while cyclophosphamide (CPA) suppressed B lymphocytes, antilymphocyte sea (ALS) suppressed both T and B cells. The humoral response of vaccinated animals treated with ALS was therefore supplemented by the i.v. injection of serum from untreated vaccinated mice. CPA-treated mice could not control multiplication of the vaccinal strain which eventually killed them. There was little multiplication of the vaccinal strain in the controls and ALS-treated mice, all of which survived to challenge. The vaccinated controls and vaccinated ALS treated groups each survived infection with the challenge strain which was gradually eliminated. It was concluded that humoral immunity was of greater importance than cellular immunity in mice vaccinated i.p. with strain G30D.

[1]  C. Muscoplat,et al.  In vitro stimulation of bovine peripheral blood lymphocytes: standardization and kinetics of the response. , 1974, American journal of veterinary research.

[2]  G. Warr,et al.  The effect of antilymphocytic antibody on the humoral immune response of different strains of mice. V. Effects on the class and subclass of antibody produced, and the antibody responses of congenitally athymic mice. , 1974, Clinical and experimental immunology.

[3]  A. Glynn,et al.  Natural resistance to Salmonella infection, delayed hypersensitivity and Ir genes in different strains of mice , 1974, Nature.

[4]  F. Dixon,et al.  Effect of irradiation and cyclophosphamide on anti-KLH antibody formation in mice. , 1974, Journal of immunology.

[5]  R. Liske A comparative study of the action of cyclophosphamide and procarbazine on the antibody production in mice. , 1973, Clinical and experimental immunology.

[6]  R. Germanier Immunity in Experimental Salmonellosis III. Comparative Immunization with Viable and Heat-Inactivated Cells of Salmonella typhimurium , 1972, Infection and immunity.

[7]  E. Fuerer,et al.  Immunity in Experimental Salmonellosis II. Basis for the Avirulence and Protective Capacity of gal E Mutants of Salmonella typhimurium , 1971, Infection and immunity.

[8]  R. Germanier Immunity in Experimental Salmonellosis I. Protection Induced by Rough Mutants of Salmonella typhimurium , 1970, Infection and immunity.

[9]  E. Lance The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives. , 1970, Clinical and experimental immunology.

[10]  P. Baker,et al.  Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum. , 1970, Journal of immunology.

[11]  W. Howson,et al.  “Lymphokines”: Non-Antibody Mediators of Cellular Immunity generated by Lymphocyte Activation , 1969, Nature.

[12]  C. Jenkin,et al.  Further studies regarding the question of cellular immunity in mouse typhoid. , 1968, The Australian journal of experimental biology and medical science.

[13]  G. Mackaness,et al.  MECHANISMS OF ACQUIRED RESISTANCE IN MOUSE TYPHOID , 1966, The Journal of experimental medicine.

[14]  D. Ushiba Two types of immunity in experimental typhoid; "cellular immunity" and "humoral immunity". , 1965, The Keio journal of medicine.

[15]  T. Fukasawa,et al.  Galactose-sensitive mutants of Salmonella. II. Bacteriolysis induced by galactose. , 1961, Biochimica et biophysica acta.

[16]  T. Fukasawa,et al.  Formation of phage receptors induced by galactose in a galactose-sensitive mutant of Salmonella. , 1960, Virology.